Found: 147
Select item for more details and to access through your institution.
Peri-Transplant Inflammation and Long-Term Diabetes Outcomes Were Not Impacted by Either Etanercept or Alpha-1-Antitrypsin Treatment in Islet Autotransplant Recipients.
- Published in:
- Transplant International, 2024, p. 1, doi. 10.3389/ti.2024.12320
- By:
- Publication type:
- Article
Peri-Transplant Inflammation and Long-Term Diabetes Outcomes Were Not Impacted by Either Etanercept or Alpha-1-Antitrypsin Treatment in Islet Autotransplant Recipients.
- Published in:
- Transplant International, 2024, v. 37, p. 1, doi. 10.3389/ti.2024.12320
- By:
- Publication type:
- Article
A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab.
- Published in:
- Diabetologia, 2024, v. 67, n. 1, p. 27, doi. 10.1007/s00125-023-06014-2
- By:
- Publication type:
- Article
High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment.
- Published in:
- Diabetologia, 2023, v. 66, n. 12, p. 2283, doi. 10.1007/s00125-023-06003-5
- By:
- Publication type:
- Article
Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis.
- Published in:
- Diabetologia, 2019, v. 62, n. 4, p. 655, doi. 10.1007/s00125-018-4786-9
- By:
- Publication type:
- Article
A call for improved reporting of human islet characteristics in research articles.
- Published in:
- Diabetologia, 2019, v. 62, n. 2, p. 209, doi. 10.1007/s00125-018-4784-y
- By:
- Publication type:
- Article
Type 1 diabetes: translating mechanistic observations into effective clinical outcomes.
- Published in:
- Nature Reviews Immunology, 2013, v. 13, n. 4, p. 243, doi. 10.1038/nri3422
- By:
- Publication type:
- Article
Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID‐19 patients: Comparison with influenza and pre‐pandemic data.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2482, doi. 10.1111/dom.15120
- By:
- Publication type:
- Article
Exenatide extended release in patients with type 1 diabetes with and without residual insulin production.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2045, doi. 10.1111/dom.14121
- By:
- Publication type:
- Article
Early and late C‐peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody‐positive individuals.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 6, p. 997, doi. 10.1111/dom.13982
- By:
- Publication type:
- Article
New directions in the immunology of autoimmune diabetes.
- Published in:
- 1992
- By:
- Publication type:
- editorial
Corrigendum: A carbon nanotube-polymer composite for T-cell therapy.
- Published in:
- Nature Nanotechnology, 2014, v. 9, n. 9, p. 723, doi. 10.1038/nnano.2014.197
- By:
- Publication type:
- Article
Insulin secretion in type 1 diabetes.
- Published in:
- 2004
- By:
- Publication type:
- journal article
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Intrathymic transplantation of islet antigen affects CD8+ diabetogenic T-cells resulting in tolerance to autoimmune IDDM.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Expression of Ly-6C by T lymphocytes of NOD mice after CD3-complex stimulation. Identification of activated cells during insulitis of prediabetic mice.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Variable deterioration in cortical function during insulin-induced hypoglycemia.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Glucose Counterregulation in Patients After Pancreatectomy.
- Published in:
- Diabetes, 1984, v. 33, n. 11, p. 1112, doi. 10.2337/diab.33.11.1112
- By:
- Publication type:
- Article
Human Regulatory CD8<sup>+</sup> T Cells.
- Published in:
- Annals of the New York Academy of Sciences, 2008, v. 1150, p. 234, doi. 10.1196/annals.1447.000
- By:
- Publication type:
- Article
Autoimmunity and β Cell Regeneration in Mouse and Human Type 1 Diabetes.
- Published in:
- Annals of the New York Academy of Sciences, 2007, v. 1103, p. 19, doi. 10.1196/annals.1394.006
- By:
- Publication type:
- Article
Use of Anti-CD3 Monoclonal Antibody to Induce Immune Regulation in Type 1 Diabetes.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1037, n. 1, p. 1, doi. 10.1196/annals.1337.001
- By:
- Publication type:
- Article
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 583, p. 1, doi. 10.1126/scitranslmed.abc8980
- By:
- Publication type:
- Article
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 564, p. 1, doi. 10.1126/scitranslmed.abd5487
- By:
- Publication type:
- Article
Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes.
- Published in:
- Diabetes, 2024, v. 73, n. 6, p. 823, doi. 10.2337/dbi23-0012
- By:
- Publication type:
- Article
Carbonyl Posttranslational Modification Associated With Early-Onset Type 1 Diabetes Autoimmunity.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The β-Cell in Type 1 Diabetes Pathogenesis: A Victim of Circumstances or an Instigator of Tragic Events?
- Published in:
- 2022
- By:
- Publication type:
- journal article
Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Deterrence of Rapid Metabolic Decline Within 3 Months After Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
11-OR: Assessments of Prediagnostic Metabolic Measures as Surrogate Endpoints for Type 1 Diabetes (T1D) Prevention Trials.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-11-OR
- By:
- Publication type:
- Article
1117-P: Characterizing Glucose/C-Peptide Response Curve (GCRC) Phenotypes to Enhance Selection Specificity for Type 1 Diabetes (T1D) Prevention Trials.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1117-P
- By:
- Publication type:
- Article
Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
1618-P: Insulin Secretion Variability According to the Specific Type 1 Diabetes (T1D) Risk Predictor.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1618-P
- By:
- Publication type:
- Article
99-OR: An Inflection Point (IP) of C-Peptide (C-P) Decline during Progression to Type 1 Diabetes (T1D).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-99-OR
- By:
- Publication type:
- Article
348-OR: Metabolic Phenotype of Autoantibody Positive (AbPos) Long-Term Nonprogressors (LTNPs) to Type 1 Diabetes (T1D).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-348-OR
- By:
- Publication type:
- Article
277-OR: Teplizumab Reverses the Loss of C-Peptide in Relatives at Risk for Type 1 Diabetes (T1D).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-277-OR
- By:
- Publication type:
- Article
276-OR: A 2-Dimensional (2D) Analysis of Glucose and C-Peptide Shows a Teplizumab Effect in Individuals at Risk for Type 1 Diabetes (T1D) 3 Months after Treatment.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-276-OR
- By:
- Publication type:
- Article
Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances.
- Published in:
- 2019
- By:
- Publication type:
- journal article
1689-P: Assessments of Alternative C-Peptide (C-P) Endpoints for New-Onset Type 1 Diabetes (T1D) Clinical Trials.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1689-P
- By:
- Publication type:
- Article
164-OR: Efficacy of New-Onset Type 1 Diabetes (T1D) Intervention Trials: Variation in 1-Year Outcomes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-164-OR
- By:
- Publication type:
- Article
85-OR: Modifiers of C-Peptide Change during the Progression to Type 1 Diabetes (T1D) in the TrialNet Pathway to Prevention Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-85-OR
- By:
- Publication type:
- Article
253-LB: Effect of Combined Low Dose IL-2 plus Polyclonal Tregs in Type 1 Diabetes Patients.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-253-LB
- By:
- Publication type:
- Article
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA<sub>1c</sub>, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Call for Improved Reporting of Human Islet Characteristics in Research Articles.
- Published in:
- 2019
- By:
- Publication type:
- editorial
Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes-The TrialNet Experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Humanized Mouse Model of Autoimmune Insulitis.
- Published in:
- Diabetes, 2014, v. 63, n. 5, p. 1712, doi. 10.2337/db13-1141
- By:
- Publication type:
- Article